Form 4: Eastman Chemical Director Julie Fasone Reports Transactions

Sentiment:

Statement of Changes in Beneficial Ownership


Julie Fasone, a Director at Eastman Chemical Co., reported transactions related to phantom stock units and common stock.

Summary

  • Julie Fasone, a Director at Eastman Chemical Co. (EMN), reported transactions on April 8, 2026.
  • These transactions involved phantom stock units and common stock.
  • The phantom stock units are part of the Directors' Deferred Compensation Plan and are valued at the market price of Eastman's common stock, payable in cash upon termination of service.
  • The reported transactions include the crediting of 408 phantom stock units and an automatic deferral of a portion of the director's annual retainer fees into these units.
  • Additionally, dividend equivalents were reinvested, increasing the phantom stock units.
  • Fasone beneficially owns 15,051 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily details routine compensation and ownership adjustments by a director rather than significant strategic or financial performance indicators.

Positives

  • Director Julie Fasone's transactions indicate continued participation and investment in the company's equity through deferred compensation and dividend reinvestment.
  • The automatic deferral of retainer fees suggests a structured approach to director compensation and alignment with shareholder interests.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to insider transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings, like this one from Eastman Chemical Director Julie Fasone, are standard disclosures for insider transactions. They provide transparency into how company insiders are managing their holdings, which can be a signal to the market, though often these transactions are part of pre-planned compensation or deferral programs.

Stakeholder Impact

  • Shareholders: Provides transparency into director compensation and ownership, reinforcing governance standards.
  • Employees: Indirectly reflects the company's compensation structure for its board members.

Key Dates

DateDescription
04/08/2026Earliest transaction date reported.
04/10/2026Date of signature for the filing.

Keywords

Eastman Chemical, EMN, Form 4, Director, Beneficial Ownership, Phantom Stock Units, Deferred Compensation, Common Stock, Insider Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.